Clinical Trial Update: A Study to Optimize Growth Hormone Dosing in Children With Chronic Kidney Disease by Measuring IGF-1 Levels in Blood [Phase 4]

View source ↗

Summary

Phase 4 study evaluating growth hormone dosing in children with chronic kidney disease by using IGF-1 levels to optimize therapy; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Growth Hormone Deficiency

Drugs mentioned

• Growth Hormone (Somatropin) (somatropin)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Kidney Failure, Chronic, Growth Hormone Deficiency | Phase 4 | Status: COMPLETED | Results posted: 2011-10-26